Search Results

Patient Guides for Cancer mobile app. Free NCCN Pocket Guidelines Available for Myeloproliferative Neoplasms NCCN is pleased to offer a pocket-sized version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for

to reflect the most recent updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Esophageal Cancer. The 2015 version addresses appropriate referral to cancer genetics professionals, and new recommendations for surveillance

, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), are designed to provide state-of-the-art treatment information in easy-to-understand language to people with cancer and their caregivers. NCCN

multidisciplinary breast cancer experts voted (24 For, 0 Against, 1 Abstain) in favor of maintaining the current position and recommendation in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer on the use of bevacizumab (Avastin

comments about the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), articles published in the journal, or any other topic relating to cancer prevention, detection, treatment, supportive care, or survivorship. Please send correspondence

NCCN continues to add to the library of NCCN Chemotherapy Order Templates (NCCN Templates) to improve the safe use of drugs and biologics in cancer care. The NCCN Templates, derived from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines

NCCN Guidelines® Updates: AIDS-Related Kaposi Sarcoma The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for AIDS-Related Kaposi Sarcoma published in this issue (page 171) include the latest updates. To assist readers interested in

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Kidney Cancer, published in this issue (page 71), include the latest updates. To assist readers interested in noting how the guidelines were updated, highlights of major

, visit NCCN.org . NCCN Releases New Translations of NCCN Guidelines NCCN recently posted new translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin Lymphoma, Multiple Myeloma, Non-Hodgkin’s Lymphomas, and

clinical trials conducted in our country. Using the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer at only one specific point in time as the “gold standard” may not be the most precise way to measure deviations of standard